Saisei Pharma plans clinical study of oral MAF in COVID-19 patients

The potent effect of Saisei Pharma MAF on phagocytosis is not accompanied by clinical or biochemical signs of inflammation when administered to humans. This means that our innate immunity can fight …
( read original story …)